Yang, Po-ChihPo-ChihYangChen, Yan-JunYan-JunChenLi, Xiao-YongXiao-YongLiCHIH-YANG HSIAOCheng, Bing-BingBing-BingChengGao, YuYuGaoZhou, Bai-ZhongBai-ZhongZhouChen, Sheng-YangSheng-YangChenHu, Shui-QuanShui-QuanHuZeng, QuanQuanZengKAI-WEN HUANG2021-11-262021-11-2620212234-943Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/588065Treating perihilar cholangiocarcinoma (PHCC) is particularly difficult due to the fact that it is usually in an advanced stage at the time of diagnosis. Irreversible electroporation treatment (IRE) involves the local administration of a high-voltage electric current to target lesions without causing damage to surrounding structures. This study investigated the safety and efficacy of using IRE in conjunction with intraoperative biliary stent placement in cases of unresectable PHCC.enJaundice cholangitis; biliary stent; irreversible electroporation; perihilar cholangiocarcinoma (PHCCA); unresectable abdominal neoplasms[SDGs]SDG3alanine aminotransferase; albumin; aspartate aminotransferase; bilirubin; CA 19-9 antigen; cisplatin; gemcitabine; gimeracil plus oteracil potassium plus tegafur; aged; Article; axillary lymph node dissection; bile duct carcinoma; cancer recurrence; cancer staging; cancer survival; cholecystectomy; clinical article; computer assisted tomography; controlled study; drug safety; echography; electroporation; endoscopic retrograde cholangiopancreatography; female; hospitalization; human; laparotomy; lymph node metastasis; male; nuclear magnetic resonance imaging; obstructive jaundice; operation duration; overall survival; progression free survival; prospective study; tumor growth; tumor invasion; tumor volumejournal article10.3389/fonc.2021.710536342774542-s2.0-85110211185https://api.elsevier.com/content/abstract/scopus_id/85110211185